1] Rare and emerging opportunistic fungal pathogens ... [2] A brief review of antifungal drugs ... [3] Nosocomial infections and their control ... [4] Recent advances in the genomic and molecular ... [5] Extra-intestinal and long term consequences of ... [6] Giardiasis: characteristics, pathogenesis and new insights ... [7] Giardia duodenalis in the UK: current knowledge of risk ... [8] Molecular genotyping of Giardia duodenalis ... [9] The effects of extracts from anti-diarrheic ... [10] Evaluation of Chenopodium ambrosioides ... [11] The anti-giardial effectiveness of fungal and commercial chitosan ... [12] Phytochemistry and medicinal properties of ... [13] The biological effects of Teucrium polium on ... [14] Comparative investigation of the sensitivity ... [15] Phytochemical screening, antibacterial, antifungal ... [16] Clinical and microbial epidemiology of otomycosis ... [17] Identification of Candida species isolated from ... [18] Antifungal susceptibility profile and molecular ... [19
No takes yet. Share an insight, caveat, or question.
Sabz et al. (2022) studied this question.